Bicara Therapeutics CFO Executes Stock Transactions Amid Clinical Data and Financial Performance Updates
The Chief Financial Officer of Bicara Therapeutics Inc. (NASDAQ:BCAX), Ivan Hyep, recently executed significant stock transactions, including both sales and purchases, utilizing a pre-arranged trading plan. These insider movements occurred against the backdrop of recent company developments, including the release of first-quarter 2026 financial res…